Roberta M Moretti
Overview
Explore the profile of Roberta M Moretti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
467
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cristofani R, Piccolella M, Crippa V, Tedesco B, Montagnani Marelli M, Poletti A, et al.
Cells
. 2021 Feb;
10(2).
PMID: 33562660
The cellular response to cancer-induced stress is one of the major aspects regulating cancer development and progression. The Heat Shock Protein B8 (HSPB8) is a small chaperone involved in chaperone-assisted...
2.
Fontana F, Marzagalli M, Montagnani Marelli M, Raimondi M, Moretti R, Limonta P
Int J Mol Sci
. 2020 Dec;
21(24).
PMID: 33327545
Pituitary Gonadotropin-Releasing Hormone receptors (GnRH-R) mediate the activity of the hypothalamic decapeptide GnRH, thus playing a key role in the regulation of the reproductive axis. Early-stage prostate cancer (PCa) is...
3.
Marzagalli M, Raimondi M, Fontana F, Montagnani Marelli M, Moretti R, Limonta P
Semin Cancer Biol
. 2019 Jul;
59:221-235.
PMID: 31265892
Malignant melanoma is a tumor characterized by a very high level of heterogeneity, responsible for its malignant behavior and ability to escape from standard therapies. In this review we highlight...
4.
Fontana F, Raimondi M, Di Domizio A, Moretti R, Montagnani Marelli M, Limonta P
Semin Cancer Biol
. 2019 Jun;
59:266-282.
PMID: 31233829
Melanoma is the most fatal form of skin cancer. Current therapeutic approaches include surgical resection, chemotherapy, targeted therapy and immunotherapy. However, these treatment strategies are associated with development of drug...
5.
Limonta P, Moretti R, Marzagalli M, Fontana F, Raimondi M, Montagnani Marelli M
Int J Mol Sci
. 2019 Mar;
20(4).
PMID: 30813301
Cancer represents a serious global health problem, and its incidence and mortality are rapidly growing worldwide. One of the main causes of the failure of an anticancer treatment is the...
6.
Fontana F, Raimondi M, Marzagalli M, Moretti R, Montagnani Marelli M, Limonta P
Recent Pat Anticancer Drug Discov
. 2019 Jan;
14(1):5-18.
PMID: 30652648
Background: Tocotrienols (TTs) are vitamin E derivatives naturally occurring in several plants and vegetable oils. Like Tocopherols (TPs), they comprise four isoforms, α, β, γ and δ, but unlike TPs,...
7.
Montagnani Marelli M, Marzagalli M, Moretti R, Beretta G, Casati L, Comitato R, et al.
Sci Rep
. 2016 Jul;
6:30502.
PMID: 27461002
Malignant melanoma is the leading cause of death from skin cancer. Drug toxicity and resistance represent a serious challange for melanoma treatments. Evidence demonstrates that natural compounds may play a...
8.
Marzagalli M, Casati L, Moretti R, Montagnani Marelli M, Limonta P
PLoS One
. 2015 Jul;
10(7):e0134396.
PMID: 26225426
Background: Cutaneous melanoma is an aggressive malignancy; its incidence is increasing worldwide and its prognosis remains poor. Clinical observations indicate that estrogen receptor β (ERβ) is expressed in melanoma tissues...
9.
Montagnani Marelli M, Manea M, Moretti R, Marzagalli M, Limonta P
Int J Oncol
. 2014 Oct;
46(1):243-53.
PMID: 25351635
It is well established that gonadotropin-releasing hormone receptors (GnRH-R) are expressed in different types of cancers, including castration-resistant prostate cancer (CRPC) and mediate the antiproliferative effect of GnRH analogs. Thus,...
10.
Manea M, Montagnani Marelli M, Moretti R, Maggi R, Marzagalli M, Limonta P
Recent Pat Anticancer Drug Discov
. 2014 May;
9(3):267-85.
PMID: 24844235
It is now well established that hormonal pathways are involved in the development of prostate cancer towards the castration resistant (CRPC) stage and can be effective molecular targets for novel...